INS and metabolic syndrome: A large number of preclinical studies have recently revealed that peripheral CB1 can promote energy storage, affect lipid metabolism and insulin sensitivity, and significantly contribute to the pathogenesis of obesity, metabolic syndrome, and diabetes [89–91].